直接腔静脉途径建立肝内门腔分流的适应证与临床结果

目的评估在肝静脉与门静脉间解剖异常时，经肝段下腔静脉直接穿刺门静脉分支完成肝内门腔静脉分流术(TIPS)操作的可行性和安全性，探讨其临床意义。资料与方法65例肝硬化门静脉高压患者行经肝段下腔静脉直接穿刺门静脉完成TIPS。结果65例经肝段下腔静脉TIPS均获成功，技术成功率100％，未出现与术中技术相关并发症，1年内再狭窄率明显低于常规TIPS，3例肝性脑病需限流支架置入得以控制。结论经肝段下腔静脉TIPS技术用于肝静脉与门静脉间解剖异常病例是安全、有效的，同时由于肝内分流道曲度较小，1年内支架开通率明显提高。     

经肝段下腔静脉人路经颈静脉肝内门体分流术的适应证及解剖基础

目的　探讨肝硬化门静脉高压患者肝静脉与门静脉间存在解剖异常时 ,行经肝段下腔静脉直接穿刺门静脉分支 ,完成经颈静脉肝内门体分流术 (TIPS)的适应证及相关解剖基础 ,评估其安全性和可行性。方法　 6 5例肝硬化门静脉高压患者行经肝段下腔静脉直接穿刺门静脉完成TIPS分流术。静脉曲张出血 5 2例 ,难治性腹水 12例 ,等待肝移植 1例。结果　 6 5例经肝段下腔静脉TIPS分流术均获成功 ,技术成功率 10 0 % ,未出现术中技术相关并发症 ,1年内初步开通率明显高于常规TIPS。结论　经肝段下腔静脉入路TIPS技术用于肝静脉与门静脉间解剖异常病例是安全可行的 ,结果提示由于肝内分流道曲度较小 ,1年内支架初步开通率明显提高。     

经皮经肝门腔静脉分流术

目的 评价经皮经肝途径建立门腔静脉分流术的可行性及探讨其临床意义。方法 19例门静脉高压患者行经皮经肝途径门腔静脉分流术(PTPS)。静脉曲张出血16例，难治性腹水2例，肝肺综合征1例；Child’S B级4例、C级15例。经皮经肝穿刺门静脉左支再穿刺肝段下腔静脉，经肝植入PTFE覆膜支架于门静脉左支与腔静脉之间。结果 19例经肝段下腔静脉TIPS分流术均获成功，技术成功率100％，未出现术中与操作技术相关并发症，术后门腔压力梯度平均下降13cmH2O，平均随访216d，所有患者未发生再出血，难治性腹水得到有效地控制。一年内初步开通率94．8％，明显高于传统TIPS。结论经皮经肝途径建立门腔静脉分流是安全可行的，结果 提示由于PTPS肝内具有顺直的分流道的优势，一年内支架初步开通率明显高于传统TIPS。     

经皮经肝门腔静脉分流术

目的介绍一种经皮治疗门静脉高压症的新方法,评价其安全性和可行性,探讨其潜在的临床意义。方法19例门静脉高压患者行经皮经肝门腔静脉分流术(PTPS)。其中食管胃底静脉曲张出血16例,难治性腹水2例,肝肺综合征1例;Child’sB级4例、C级15例。经皮经肝穿刺门静脉左支再穿刺肝段下腔静脉,经皮经肝方向植入PTFE覆膜支架于门静脉左支与腔静脉之间。结果19例经肝段下腔静脉PTPS分流术均获成功,技术成功率100%,未出现术中技术相关并发症,术后门腔静脉压力梯度平均下降13cmH2O,平均随访216d,所有患者未发生再出血,难治性腹水得到有效控制。1年内初步开通率94.8%,明显高于传统TIPS。结论经皮经肝途径建立门腔静脉分流是安全可行的,1年内支架初步开通率明显高于传统TIPS。     

经皮经肝门腔静脉分流术血流动力学与支架构型关系的临床研究

目的介绍一种全新肝内分流预应力支架的结构和在经皮经肝肝内门腔静脉分流术（PTPS）中应用的临床结果。分析应用该支架建立的门腔静脉分流道与经典TIPS所用支架血流动力学之间的区别,探讨其潜在的临床意义。方法38例门静脉高压患者采用预应力支架行经皮经肝途径门腔静脉分流术（PTPS）。静脉曲张出血36例,难治性腹水1例及肝肺综合征1例;Child＇s B级27例、C级11例。经皮经肝穿刺进入门静脉右支,再经门静脉左支矢状部穿刺肝段下腔静脉,经皮经肝植入预应力支架于门静脉左支与肝段下腔静脉之间。结果38例采用预应力支架行PTPS均获成功,技术成功率100％,未出现术中与技术相关并发症,术后门腔压力梯度平均下降14cmH2O,平均随访493d,所有患者未发生再出血,难治性腹水得到有效地控制。初步开通率98．9%,明显高于经典直管形裸支架TIPS。结论采用预应力支架经皮经肝途径建立门腔静脉分流是安全可行的,其血流动力学结果提示：预应力支架形状及与相关血管壁间“吻合”严密,符合正常肝内门静脉血流动力学分布,既起到门静脉部分性降压作用,亦保障了门静脉右支血流的肝内灌注,对预防术后分流道再狭窄及降低肝性脑病发生率具有明显的临床意义。     

经颈静脉肝内门体内支架分流术中经下腔静脉直接穿刺门静…

目的：通过观察肝门部门静脉、肝实质与肝后段下腔静脉之间的解剖关系，探讨经颈静脉肝内门体内支架分流术（ＴＩＰＳＳ）中经下腔静脉直接穿刺门静脉分支的可行性。材料与方法：观察１０例新鲜人体尸检正常肝脏标本的肝后段下腔静脉与肝脏以及门静脉分岐部、门静脉左右主支与肝脏和肝后段下腔静脉间的解剖关系，并对１０％福尔马林固定后的标本做光镜下观察。结果：１０例标本中，肝后段下腔静脉的一部分通过肝尾状叶与门静脉分歧部     

预应力支架的结构与经皮经肝肝内门腔静脉分流术血流动力学关系的研究

目的介绍一种全新肝内分流支架的结构和在经皮经肝肝内门腔静脉分流术(PTPS)中应用的临床结果。分析应用该支架建立的门腔静脉分流道与经典TIPS所用支架血流动力学之间的差异,探讨其潜在的临床意义。方法38例门静脉高压症患者采用预应力支架行PTPS。其中静脉曲张出血36例,难治性腹水1例及肝肺综合征1例;肝功能Child Pugh B级27例、C级11例。经皮经肝穿刺进入门静脉右支,再经门静脉左支矢状部穿刺肝段下腔静脉,经皮经肝植入预应力支架于门静脉左支与肝段下腔静脉之间。结果38例采用预应力支架行PTPS均获成功,技术成功率100%,术中未出现与技术相关并发症,术后门腔压力梯度平均下降14 cmH_2O,平均随访493 d,所有患者未发生再出血,难治性腹水得到有效地控制。初步开通率达98．9%。结论采用预应力支架经皮经肝途径建立门腔静脉分流安全可行,其血流动力学结果提示预应力支架形态及与相关血管壁间“吻合”严密,符合正常肝内门静脉血流动力学分布,既起到门静脉部分性降压作用,又保障了门静脉右支血流的肝内灌注,对术后预防分流道再狭窄及降低肝内分流术后肝性脑病发生率具有重要的临床意义。     

经颈内静脉肝内门腔静脉分流术治疗BuddChiari综合征

目的探讨经颈静脉肝内门腔静脉分流术(TIPS)治疗Budd-Chiari综合征(BCS)的疗效。方法本组14例患者经影像学检查确诊为BCS,因进行性肝功能损害,或严重门脉高压并发症(顽固性腹水,食管胃底静脉曲张上消化道出血),或广泛肝静脉闭塞而行TIPS术治疗。其中混合型8例,肝静脉型5例,肝静脉广泛闭塞型1例。TIPS术中对于下腔静脉、肝静脉的不同情况,灵活选择肝静脉或下腔静脉穿刺点进行穿刺,7例从肝静脉开口处行门静脉穿刺,建立门-腔静脉分流道,4例从下腔静脉直接穿刺门静脉分支,3例经皮穿刺开通肝右静脉后再经肝右静脉穿刺门静脉。术后对分流道支架开通情况进行长期随访。结果14例手术均获成功,门静脉压力由术前平均(4.9±1.4)kPa,降至术后(3.2±1.5)kPa,术后随访5～64个月,2例因支架狭窄分别于术后13、24个月再发上消化道出血,行分流道球囊扩张治疗,术后恢复良好。结论TIPS适用BCS合并有进行性肝功能损害或门静脉高压引起的上消化道出血、顽固性腹水的治疗。对于已行下腔静脉或肝静脉成形术后再发或加重的门静脉高压患者亦为适应证,但手术难度增加。     

改良式经颈静脉肝内门腔静脉分流术治疗肝静脉闭塞型Buddi-Chiari 综合征

目的阐述改良式经颈静脉肝内门腔静脉分流术(TIPS)的技术步骤和评价其对肝静脉闭塞型Buddi-Chiari综合征的治疗效果.方法 11例被诊断为Buddi-Chiari综合征的患者,经影像学证实为肝静脉广泛狭窄和闭塞后,接受改良式TIPS技术治疗,TIPS改良技术的关键在于假想肝静脉通道的设计与建立;术后对其门脉系统压力变化、分流道血流改变及内支架开通状况进行了24个月的随访.结果 11例患者全部成功地建立肝内门静脉-下腔静脉分流通道,临床症状得到改善;门静脉主干压力由分流前的平均(4.62±0.52) kPa (1 kPa=10.2 cm H2O)下降至分流术后的(2.16±0.21) kPa;术后24个月随访,分流道血液最大流率(Vmax)为(56.2±3.50) cm/s,内支架通畅7(7/11)例.结论改良式TIPS技术具有高技术成功率,为肝静脉闭塞型Buddi-Chiari综合征患者提供了新的治疗手段.     

经颈静脉肝内门体内支架分流术中经下腔静脉直接穿刺门静脉分支的可行性研究

目的：通过观察肝门部门静脉、肝实质与肝后段下腔静脉之间的解剖关系，探讨经颈静脉肝内门体内支架分流术（ＴＩＰＳＳ）中经下腔静脉直接穿刺门静脉分支的可行性。材料与方法：观察１０例新鲜人体尸检正常肝脏标本的肝后段下腔静脉与肝脏以及门静脉分歧部、门静脉左右主支与肝脏和肝后段下腔静脉间的解剖关系，并对１０％福尔马林固定后的标本做光镜下观察。结果：１０例标本中，肝后段下腔静脉的一部分通过肝尾状叶与门静脉分歧部相连。门静脉分歧部及左右主支均位于肝外。门脉分歧部与门脉左右主支的上壁、后上壁与肝实质连接紧密。光镜下见门静脉分歧部、门静脉左右主支与肝实质间存在致密结缔组织。结论：肝外门静脉分歧部、门静脉左右主支均可作为ＴＩＰＳＳ术中的安全穿刺点；经下腔静脉直接穿刺门静脉分支，在一些情况下，可以作为一种新的ＴＩＰＳＳ入路。     

Transcaval Transjugular Intrahepatic Portosystemic Shunt: Preliminary Clinical Results

Objective

To determine the feasibility of transcaval transjugular intrahepatic portosystemic shunt (TIPS) creation in patients with unusual anatomy between the hepatic veins and portal bifurcation, and inaccessible or inadequate hepatic veins.

Materials and Methods

Transcaval TIPS, performed in six patients, was indicated by active variceal bleeding (n=2), recurrent variceal bleeding (n=2), intractable ascites (n=1), and as a bridge to liver transplantation (n=1). The main reasons for transcaval rather than classic TIPS were the presence of an unusually acute angle between the hepatic veins and the level of the portal bifurcation (n=3), hepatic venous occlusion (n=2), and inadequate small hepatic veins (n=1).

Results

Technical and functional success was achieved in all patients. The entry site into liver parenchyma from the inferior vena cava was within 2 cm of the atriocaval junction. Procedure-related complications included the death of one patient due to hemoperitoneum despite the absence of contrast media spillage at tractography, and another suffered reversible hepatic encephalopathy.

Conclusion

In patients with unusual anatomy between the hepatic veins and portal bifurcation, and inaccessible or inadequate hepatic veins, transcaval TIPS creation is feasible.     

改良式TIPS的解剖学基础研究

目的 探讨肝硬化门脉高压患者下腔静脉、肝静脉与门静脉三者之间的影像解剖学关系,评估改良式TIPS,即经肝段下腔静脉入路经颈静脉肝内门体分流术的安全性与可行性.方法 64例临床证实的肝硬化患者,肝功能Child-Pugh B级40例,C级24例,行肝脏双期增强扫描后行CT多层面重组(MPR)及曲面重建(CPR)后处理,将测量所得数据进行配对t检验.结果 Child-Pugh B级者肝段下腔静脉的长度与C级者相比前者较长(P＜0.05).以肝段下腔静脉穿刺点为A1,肝右静脉开口2 cm处的穿刺点为A2,门静脉分叉部穿刺点为B1,门静脉右支开口2 cm处的穿刺点为B2,A1 B1线的长度与A2 B1线的长度相比前者较短(P＜0.05),A1 B2线和A2 B2线与B2点所在门静脉右支径线的夹角大小相比前者较小(P＜0.05).A1 B1线和A1 B2线分别与所在门静脉径线的夹角相比前者较大(P＜0.05),A2 B1线和A2 B2线分别与所在门静脉径线的夹角相比前者较大(P＜0.05).结论 从解剖学角度分析,改良式TIPS具备安全性及可行性,较传统TIPS术式还具有分流道走行顺畅,对血流动力学影响小的优点.     

Ultrasonography-guided percutaneous transhepatic portacaval shunt creation

We successfully created a percutaneous transhepatic portacaval shunt under ultrasonography (US) guidance in a 46-year-old man with refractory ascites. The shunt was created to salvage an attempt to create a transjugular intrahepatic portosystemic shunt (TIPS) that failed because of the elevated level of portal vein bifurcation due to alcoholic liver cirrhosis. Under US guidance, we simultaneously punctured the right branch of the portal vein and the inferior vena cava (IVC) using a two-step biliary drainage set. An Amplatz gooseneck snare was introduced transjugularly to retrieve the percutaneously inserted guidewire. The intrahepatic tract between the portal vein and the IVC was dilated using a balloon catheter, and a stent was placed in the tract. The patient showed complete resolution of ascites at discharge. We assume that our method is an alternative method for TIPS creation in patients with inadequate anatomical relations between the portal vein branches and the hepatic veins. This approach is thought to be feasible for patients with occluded or small hepatic veins.     

Transcaval TIPS in Patients with Failed Revision of Occluded Previous TIPS

Objective

To determine the feasibility of transcaval transjugular intrahepatic portosystemic shunt (TIPS) in patients with occluded previous TIPS.

Materials and Methods

Between February 1996 and December 2000 we performed five transcaval TIPS procedures in four patients with recurrent gastric cardiac variceal bleeding. All four had occluded TIPS, which was between the hepatic and portal vein. The interval between initial TIPS placement and revisional procedures with transcaval TIPS varied between three and 31 months; one patient underwent transcaval TIPS twice, with a 31-month interval. After revision of the occluded shunt failed, direct cavoportal puncture at the retrohepatic segment of the IVC was attempted.

Results

Transcaval TIPS placement was technically successful in all cases. In three, tractography revealed slight leakage of contrast materials into hepatic subcapsular or subdiaphragmatic pericaval space. There was no evidence of propagation of extravasated contrast materials through the retroperitoneal space or spillage into the peritoneal space. After the tract was dilated by a bare stent, no patient experienced trans-stent bleeding and no serious procedure-related complications occurred. After successful shunt creation, variceal bleeding ceased in all patients.

Conclusion

Transcaval TIPS placement is an effective and safe alternative treatment in patients with occluded previous TIPS and no hepatic veins suitable for new TIPS.     

Ultrasound-guided transhepatic puncture of the hepatic veins for TIPS placement

Purpose

This retrospective analysis was carried out to assess the feasibility and results of transjugular intrahepatic portal systemic shunt (TIPS) performed with ultrasound (US)-guided percutaneous puncture of the hepatic veins.

Material and methods

Over a period of 3 years, 153 patients were treated with TIPS at our centre. In eight cases, a percutaneous puncture of the middle (n=7) or right (n=1) hepatic vein was required because the hepatic vein ostium was not accessible. Indications for TIPS were bleeding (n=1), Budd-Chiari syndrome (n=1), ascites (n=2), reduced portal flow (n=1) and incomplete portal thrombosis (n=3). A 0.018-in. guidewire was anterogradely introduced into the hepatic vein to the inferior vena cava (IVC) through a 21-gauge needle. In the meantime, a 25-mm snare-loop catheter was introduced through the jugular access to retrieve the guidewire, achieving through-andthrough access. Then, a Rosch-Uchida set was used to place the TIPS with the traditional technique.

Results

Technical success was achieved in all patients. There was one case of stent thrombosis. One patient died of pulmonary oedema. Three patients were eligible for liver transplantation, whereas the others were excluded due to shunt thrombosis (n=1) and previous nonhepatic neoplasms (n=3).

Conclusions

The percutaneous approach to hepatic veins is rapid and safe and may be useful for avoiding traumatic liver injuries.     

Portal flow and arterioportal shunting after transjugular intrahepatic portosystemic shunt creation

PURPOSE: It was postulated that a transjugular intrahepatic portosystemic shunt (TIPS) produces arterioportal shunting and accounts for reversed flow in the intrahepatic portal veins (PVs) after creation of the TIPS. This study sought to quantify this shunting in patients undergoing TIPS creation and/or revision with use of a direct catheter-based technique and by measuring changes in blood oxygenation within the TIPS and the PV. MATERIALS AND METHODS: This prospective study consisted of 26 patients. Median Model for End-stage Liver Disease and Child-Pugh scores were 13 and 9, respectively. Primary TIPS creation was attempted in 21 patients and revision of failing TIPS was undertaken in five. In two patients, TIPS creation was unsuccessful. All TIPS creation procedures but one were performed with use of polytetrafluoroethylene-covered stent-grafts. Flow within the main PV (Q(portal)) was measured with use of a retrograde thermodilutional catheter before and after TIPS creation/revision, and TIPS flow (Q(TIPS)) was measured at procedure completion. The amount of arterioportal shunting was assumed to be the increase between final Q(portal) and Q(TIPS), assuming Q(TIPS) was equivalent to the final Q(portal) plus the reversed flow in the right and left PVs. Oxygen saturation within the TIPS and the PV was determined from samples obtained during TIPS creation and revision. RESULTS: Mean Q(portal) before TIPS creation was 691 mL/min; mean Q(portal) after TIPS creation was 1,136 mL/min, representing a 64% increase (P = .049). Mean Q(TIPS) was 1,631 mL/min, a 44% increase from final Q(portal) (P = .0009). Among cases of revision, baseline Q(portal) was 1,010 mL/min and mean Q(portal) after TIPS revision was 1,415 mL/min, a 40% increase. Mean Q(TIPS) was 1,693 mL/min, a 20% increase from final Q(portal) (P = .42). Arterioportal shunting rates were 494 mL/min after TIPS creation and 277 mL/min after TIPS revision, representing 30% of total Q(TIPS) after TIPS creation and 16% of Q(TIPS) after TIPS revision. No increase in oxygen tension or saturation was seen in the PV or TIPS compared with initial PV levels. Q(TIPS) did not correlate with the portosystemic gradient. CONCLUSION: TIPS creation results in significant arterioportal shunting, with less arterioportal shunting seen among patients who undergo TIPS revision. Further work is necessary to correlate Q(TIPS) with the risk of hepatic encephalopathy and liver failure.     

Transjugular intrahepatic portosystemic shunt creation with the Viatorr expanded polytetrafluoroethylene-covered stent-graft

PURPOSE: To evaluate the midterm clinical results and patency of transjugular portosystemic shunts (TIPS) created with a commercially available expanded polytetrafluoroethylene (ePTFE)-covered stent-graft based on angiographic and ultrasonographic (US) criteria in a series of 71 patients. MATERIALS AND METHODS: Seventy-one patients (61 men, 10 women; mean age, 58.6 years, range, 25-78 years) were included in this series, which was performed in two centers. Indications for TIPS creation were refractory ascites (n = 44) and recurrent esophageal bleeding (n = 27). Ten patients had Child-Pugh class A liver cirrhosis, 43 had class B disease, and 18 had class C disease. Underlying liver diseases were alcoholic cirrhosis (n = 58), cirrhosis resulting from hepatitis (n = 9), cryptogenic cirrhosis (n = 3), and Budd-Chiari syndrome (n = 1). TIPS were created with commercially available ePTFE-covered stent-grafts in all patients. The diameters of the stent-grafts were 10 mm in 58 patients and 8 mm in the remaining 13 patients. Follow-up included clinical examination and color-coded US after 5 days, 1, 3, and 6 months, and every 6 months thereafter. Shunt angiograms were obtained every 6 months. Median follow-up was 16.3 months (range, 3.8-26.6 months). RESULTS: TIPS creation was successful in all patients without complications, and effective portal decompression was observed with a reduction of the mean portal gradient from 19 mm Hg to 6 mm Hg before and after TIPS creation. Four shunt occlusions were observed after 5 days, 2 months, 3 months, and 6 months. Shunt stenosis was observed in three patients at the hepatic vein, which was not fully covered by the stent-graft, after 6 months (n = 2) and 12 months, and at the portal side after 1 month in a patient who initially had portal vein thrombosis. The repeat intervention rate was 11.3%. The primary patency rates were 87.4% (95% CI, 77.7%-97.1%) after 6 months and 80.8% (95% CI, 68.2%-93.4%) after 12 months. The rate of de novo or deteriorated hepatic encephalopathy was 31%. The recurrent bleeding rate was 3.7% (one of 27), and ascites improved or resolved in 64% of patients after 1 month. CONCLUSION: TIPS patency can be significantly increased if the ePTFE-covered stent-graft is used for shunt creation. The increased shunt patency contributes to low repeat intervention and recurrent bleeding rates. The rate of hepatic encephalopathy is within the range of previously reported rates.     

Main portal vein access in transjugular intrahepatic portosystemic shunt procedures: use of three-dimensional ultrasound to ensure safety

PURPOSE: To document the safety of main portal vein (PV) access to create transjugular portosystemic intrahepatic shunts (TIPS), provided that three-dimensional ultrasonography (3D US) can document the puncture to have entered a surface of the PV suitable for tamponade. MATERIALS AND METHODS: In 11 patients who underwent conventional TIPS creation (n = 10) or a transjugular portacaval shunt procedure (n = 1), the puncture was found angiographically to enter the main PV. In seven cases, this occurred at the PV bifurcation and, in four, it occurred in the superior third of the PV. 3D US was used to determine whether the point of PV entry was functionally intrahepatic or extrahepatic. The puncture site was deemed to be intrahepatic if liver covered the puncture site on all three orthogonal imaging planes (sagittal, coronal, and transverse). If the puncture site was surrounded by liver, the access was used to deploy a metallic stent (uncovered, n = 10; covered, n = 1). Medical records and follow-up cross-sectional imaging studies were reviewed for evidence of hemorrhage complications. Pathologic correlation was performed in one explanted liver and autopsy specimens in five other patients. RESULTS: In nine of 11 patients, 3D US was diagnostic and confidently verified that liver completely covered the portal vein access site. In two patients with diagnostically uncertain 3D US results, transcatheter injection of contrast medium documented no extravasation. All TIPS and direct portacaval shunt procedures were technically successful. No hemorrhagic complications occurred. Examination of pathologic specimens documented this portion of the portal vein to be extraperitoneal, but attached to the superior surface of the caudate lobe with fibrous tissue and small portal vein branches. CONCLUSIONS: The bifurcation and posterior aspect of the superior third of the main PV can be safely used for TIPS procedures, provided access is proven to be surrounded by liver. 3D US can usually confidently determine if the PV entry site is functionally intrahepatic.